Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design

Journal of Liposome Research

Volumn 22, Issue 4, 2012, Pages 270-278

  Shi, Jun ^a   Ma, Fangli ^b   Wang, Xiaoyan ^a   Wang, Fang ^a   Liao, Huawei ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b Infinitus (China) Company Ltd   (China)

Author keywords

Drug design; Factorial design; Hypertrophic scars; Paeonol; Transdermal drug delivery

Indexed keywords

LIPOSOME; PEONOL; POLYMER;

ANIMAL TISSUE; ARTICLE; DEPENDENT VARIABLE; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; HYPERTROPHIC SCAR; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VISCOSITY;

ACETOPHENONES; ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; GELS; LIPOSOMES;

EID: 84870268061     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.690159     Document Type: Article

References (29)

1. Aarabi, S., Longaker, M. T., Gurtner, G. C. (2007). Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 4:234-257.
2. Abd, E. B., Tayel, S., Amin, S. Y., Osman, A. (1992). Bioavailability of salbutamol sulphate from diferent suppository formulations. Egypt J Pharm Sci 33:1031-1043.
3. Aggarwal B. B., Ichikawa H., Garodia P., Weerasinghe P., Sethi G., Bhatt, I. D., et al. (2006). From traditional Ayurvedic medicine to modern medicine: identifcation of therapeutic targets for suppression of infammation and cancer.Expert Opin Ter Targets 10:87-118. (Pubitemid 43263269)
4. Agyralides, G. G., Dallas, P. P., Rekkas, D. M. (2004). Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int J Pharm 281:35-43. (Pubitemid 39024261)
5. Brissett, A. E., Sherris, D. A. (2001). Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg 17:263-272.
6. Campanati, A., Savelli, A., Sandroni, L., Marconi, B., Giuliano, A., Giuliodori, K., et al. (2010). Efect of allium cepallantion-pentaglycan gel on skin hypertrophic scars: clinical and video-capillaroscophic results of an open-label, controlled, nonrandomized clinical trials. Dermatol Surg 36:1439-1444.
7. Cevc, G., Schätzlein, A., Richardsen, H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564:21-30. (Pubitemid 34717865)
8. Ebdon, J. R., Jones, M. S. (1996). Flame retardants (overview). In: Salomone, J. C. (Ed.), Polymeric materials encyclopedia (pp. 2397-2411). London: CRC.
9. Ferreira, L. S., Ramaldes, G. A., Nunan, E. A., Ferreira, L. A. (2004). In vitro skin permeation and retention of paromomycin from liposomes for tropical treatment of the cutaneous leishmaniasis. Drug Dev Ind Pharm 30:289-296. (Pubitemid 38451753)
10. Hema, C., Kanchan, K., Saima, A., Rathee, P., Kumar, V. (2011). Optimization and formulation design of gels of diclofenac and curcumin for transdermal drug delivery by Box-Behnken statistical design. J Pharm Sci 100:580-593.
11. Hernández-Casselles, T., Villalaín, J., Gómez-Fernández, J. C. (1993). Infuence of liposome charge and composition on their interaction with human blood serum protein. Mol Cell Biochem 120:119-126. (Pubitemid 23111170)
12. Kim, S. A., Lee, H. J., Ahn, K. S., Lee, H. J., Lee, E. O., Ahn, K. S., et al. (2009). Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of akt activation and inactivation of matrix metalloproteinase. Biol Pharm Bull 32:1142-1147.
13. Krishnaiah, Y. S., Satyanarayana, V., Bhasker, P. (2003). Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin. Drug Dev Ind Pharm 29:191-202. (Pubitemid 36292942)
14. Kumar, I., Staton, C. A., Cross, S. S., Reed, M. W., Brown, N. J. (2009). Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg 96:1484-1491.
15. Lee, H. J., Kim, S. A., Lee, H. J., Jeong, S. J., Han, I., Jung, S. H., et al. (2010). Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fbrosarcoma cells. PLoS One 5: e12358.
16. Maintani, Y., Soeda, H., Wang, J., Takayama, K. (2001). Modifed ethanol injection method for liposomes containing β-sitosterol β-D-glucoside. J Liposome Res 11:115-125. (Pubitemid 32436259)
17. Namba, Y., Sakakibara, T., Masada, M., Ito, F., Oku, N. (1990). Glucuronate-modifed liposomes with prolonged circulation time. Chem Pharm Bull 38:1663-1666. (Pubitemid 20265647)
18. Patel, R. P., Patel, H. H., Baria, A. H. (2009). Formulation and evaluation of Carbopol gel containing liposomes of ketoconazole. Int J Drug Deliv Technol 1:42-45.
19. Peng, X. S., Wen, X. G., Pan, X., Wang, R., Chen, B., Wu, C. (2010). Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels. AAPS 11:1405-1410.
20. Pons, M., Foradada, M., Estelrich, J. (2003). Liposomes obtained by the ethanol injection method. Int J Pharm 95:51-56.
21. Rakesh, P., Hardik, H., Ashok, H., et al. (2009). Formulation and evaluation of Carbopol gel containing liposomes of ketoconazole[J]. International Journal of Drug Delivery Rakesh P, Hardik H, Ashok H, et al. Formulation and evaluation of Carbopol gel containing liposomes of ketoconazole[J]. International Journal of Drug Delivery Technology 1:42-45.
22. Rao, P. R., Diwan, P. V. (1998). Formulation and in vitro evaluation of polymeric flms of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm 24:327-336. (Pubitemid 28204501)
23. Sales, O. D., Garrigues, T. M., Herráez, J. V. (2005). In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-phydrogels: infuence of propylene glycol. J Pharm Sci 94:1039-1047. (Pubitemid 40780770)
24. Signorini, M., Clementoni, M. T. (2007). Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg 31:183-187. (Pubitemid 46625377)
25. Trotta, M., Peira, E., Carlotta, M. E., Gallarate, M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119-125. (Pubitemid 38077093)
26. Wang, X. Q., Liu, Y. K., Qing, C., Lu, S. L. (2009). Hyperactivity of broblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. Microvasc Res 77:204-211.
27. Van der Veer, W. M., Niessen, F. B., Ferreira, J. A., Zwiers, P. J., de Jong, E. H., Middelkoop, E., et al. (2011). Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 77:292-301.
28. Zhu, K. Q., Engrav, L. H., Armendariz, R., Muangman, P., Klein, M. B., Carrougher, G. J., et al. (2005). Changes in VEGF and nitric oxide after deep dermal injury in the female, red Duroc pig-further similarities between female, Duroc scar and human hypertrophic scar. Burns 31:5-10. (Pubitemid 40082642)
29. Zurada J. M., Kriegel D., Davis I. C. (2006). Topical treatments for hypertrophic scars. J Am Acad Dermatol 55(10):1024-1031. (Pubitemid 44716469)